Does the type of parenteral lipids matter? A clinical hint in critical illness

Clinical Nutrition

Volumn 36, Issue 2, 2017, Pages 491-496

  Devaud, J C ^a,b   Berger, M M ^a   Pannatier, A ^a,b   Sadeghipour, F ^a,b   Voirol, P ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Hypertriglyceridemia; ICU; Lipid metabolism; Nutrition; Propofol; Sedation

Indexed keywords

FATTY ACID; TRIACYLGLYCEROL; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LIPID EMULSION; MONOUNSATURATED FATTY ACID;

ADULT; AGED; ARTICLE; CALORIC INTAKE; CRITICAL ILLNESS; DEMOGRAPHY; DISEASE SEVERITY; EMULSION; FEMALE; GLUCOSE INTAKE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; RETROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; ADMINISTRATION AND DOSAGE; BLOOD; FAT INTAKE; INCIDENCE; INTENSIVE CARE UNIT; MIDDLE AGED; NUTRITIONAL REQUIREMENT; PROTEIN INTAKE;

AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CRITICAL ILLNESS; DIETARY FATS; DIETARY PROTEINS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NUTRITIONAL REQUIREMENTS; PARENTERAL NUTRITION; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 84962052524     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2016.01.009     Document Type: Article

References (36)

1. [1] Berger, M., Pichard, C., Development and current use of parenteral nutrition in critical care – an opinion paper. Crit Care, 18, 2014, 478.
2. [2] Preiser, J., van Zanten, A., Berger, M., Biolo, G., Casaer, M., Doig, G., et al. Metabolic and nutritional support of critically ill patients: consensus and controversies. Crit Care, 19, 2015, 35.
3. [3] Singer, P., Berger, M.M., Van den Berghe, G., Biolo, G., Calder, P., Forbes, A., et al. ESPEN Guidelines on parenteral nutrition: intensive care. Clin Nutr 28 (2009), 387–400.
4. [4] Bach, A.C., Storck, D., Meraihi, Z., Medium-chain triglyceride-based fat emulsions: an alternative energy supply in stress and sepsis. J Parenter Enteral Nutr 12 (1988), 82S–88S.
5. [5] Calder, P.C., Lipids for intravenous nutrition in hospitalised adult patients: a multiple choice of options. Proc Nutr Soc 72 (2013), 263–276.
6. [6] Shams, M.R., Tavassoli, N., Plicaud, H., Genestal, M., Incidence and risk factors of hypertriglyceridemia in the ICU. Crit Care Med, 13, 2009, 130.
7. [7] Ziegler, T.R., Parenteral nutrition in the critically ill patient. N Engl J Med 361 (2009), 1088–1097.
8. [8] Manzanares, W., Dhaliwal, R., Jurewitsch, B., Stapleton, R.D., Jeejeebhoy, K.N., Heyland, D.K., Alternative lipid emulsions in the critically ill: a systematic review of the evidence. Intensive Care Med 39 (2013), 1683–1694.
9. [9] Marik, P.E., Dyslipidemia in the critically ill. Crit Care Clin 22 (2006), 151–159 viii.
10. [10] Berger, M.M., The 2013 Arvid Wretlind lecture: evolving concepts in parenteral nutrition. Clin Nutr 33:4 (2014 Aug), 563–570.
11. [11] Adolph, M., Lipid emulsions in parenteral nutrition. Ann Nutr Metab 43 (1999), 1–13.
12. [12] Ton, M.N., Chang, C., Carpentier, Y.A., Deckelbaum, R.J., In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides. Clin Nutr 24 (2005), 492–501.
13. [13] Wanten, G., An update on parenteral lipids and immune function: only smoke, or is there any fire?. Curr Opin Clin Nutr Metab Care 9 (2006), 79–83.
14. [14] Reimund, J.M., Rahmi, G., Escalin, G., Pinna, G., Finck, G., Muller, C., et al. Efficacy and safety of an olive oil-based intravenous fat emulsion in adult patients on home parenteral nutrition. Aliment Pharmacol Ther 21 (2005), 445–454.
15. [15] Gibbons, R.J., Abrams, J., Chatterjee, K., Daley, J., Deedwania, P.C., Douglas, J.S., et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina – summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol, 41, 2003, 159.
16. [16] Berger, M., Chioléro, R., Pannatier, A., Cayeux, C., Tappy, L., A 10-year survey of nutritional support in a surgical ICU: 1986–1995. Nutrition 13 (1997), 870–877.
17. [17] Devaud, J.C., Berger, M.M., Pannatier, A., Marques-Vidal, P., Tappy, L., Rodondi, N., et al. Hypertriglyceridemia: a potential side effect of propofol sedation in critical illness. Intensive Care Med 38 (2012), 1990–1998.
18. [18] Oddo, M., Sedat and analgesia skills and techniques. 2010, ESICM, 56.
19. [19] Grau, T., Bonet, A., Rubio, M., Mateo, D., Farré, M., Acosta, J.A., et al. Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care, 11, 2007, R10.
20. [20] Berger, M.M., Revelly, J.P., Wasserfallen, J.B., Schmid, A., Bouvry, S., Cayeux, M.C., et al. Impact of a computerized information system on quality of nutritional support in the ICU. Nutrition 22 (2006), 221–229.
21. [21] Druml, W., Fischer, M., Pidlich, J., Lenz, K., Fat elimination in chronic hepatic failure: long-chain vs medium-chain triglycerides. Am J Clin Nutr 61 (1995), 812–817.
22. [22] Wirtitsch, M., Wessner, B., Spittler, A., Roth, E., Volk, T., Bachmann, L., et al. Effect of different lipid emulsions on the immunological function in humans: a systematic review with meta-analysis. Clin Nutr 26 (2007), 302–313.
23. [23] Kreymann, K.G., Berger, M.M., Deutz, N.E., Hiesmayr, M., Jolliet, P., Kazandjiev, G., et al. ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr 25 (2006), 210–223.
24. [24] Allingstrup, M.J., Esmailzadeh, N., Wilkens Knudsen, A., Espersen, K., Hartvig Jensen, T., Wiis, J., et al. Provision of protein and energy in relation to measured requirements in intensive care patients. Clin Nutr 31 (2012), 462–468.
25. [25] Weijs, P., Stapel, S., de Groot, S., Driessen, R., de Jong, E., Girbes, A., et al. Optimal protein and energy nutrition decreases mortality in mechanically ventilated, critically ill patients: a prospective observational cohort study. J Parenter Enteral Nutr 36 (2012), 60–68.
26. [26] Bauer, P., Charpentier, C., Bouchet, C., Nace, L., Raffy, F., Gaconnet, N., Parenteral with enteral nutrition in the critically ill. Intensive Care Med 26 (2000), 893–900.
27. [27] Jeejeebhoy, K.N., Parenteral nutrition in the intensive care unit. Nutr Rev 70 (2012), 623–630.
28. [28] Crook, M.A., Lipid clearance and total parenteral nutrition: the importance of monitoring plasma lipids. Nutrition 16 (2000), 774–775.
29. [29] Nordenstrom, J., Carpentier, Y.A., Askanazi, J., Robin, A.P., Elwyn, D.H., Hensle, T.W., et al. Metabolic utilization of intravenous fat emulsion during total parenteral nutrition. Ann Surg 196 (1982), 221–231.
30. [30] Tappy, L., Schwarz, J., Schneiter, P., Cayeux, C., Revelly, J., Fagerquist, C., et al. Effects of isoenergetic glucose-based or lipid-based parenteral nutrition on glucose metabolism, de novo lipogenesis, and respiratory gas exchanges in critically ill patients. Crit Care Med 26 (1998), 860–867.
31. [31] Tappy, L., Berger, M.M., Schwarz, J.M., Schneiter, P., Kim, S., Revelly, J.P., et al. Metabolic effects of parenteral nutrition enriched with n-3 polyunsaturated fatty acids in critically ill patients. Clin Nutr 25 (2006), 588–595.
32. [32] Llop, J., Sabin, P., Garau, M., Burgos, R., Perez, M., Masso, J., et al. The importance of clinical factors in parenteral nutrition-associated hypertriglyceridemia. Clin Nutr 22:6 (2003 Dec), 577–583.
33. [33] Chiarla, C., Giovannini, I., Giuliante, F., Zadak, Z., Vellone, M., Ardito, F., et al. Severe hypocholesterolemia in surgical patients, sepsis, and critical illness. J Crit Care, 25, 2010, 361 e7–e12.
34. [34] Chambrier, C., Lauverjat, M., Bouletreau, P., Emulsions lipidiques: indication des différentes émulsions lipidiques. Nut Clin Metabol 20 (2006), 73–78.
35. [35] McLeod, G., Dick, J., Wallis, C., Patterson, A., Cox, C., Colvin, J., Propofol 2% in critically ill patients: effect on lipids. Crit Care Med 25 (1997), 1976–1981.
36. [36] Edmunds, C.E., Brody, R.A., Parrott, J.S., Stankorb, S.M., Heyland, D.K., The effects of different IV fat emulsions on clinical outcomes in critically ill patients. Crit Care Med 42 (2014), 1168–1177.